ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. (SPRY) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 224 transactions totaling $127.9M, demonstrating a bearish sentiment with -$25.4M in net insider flow. The most recent transaction on Nov 13, 2025 involved a sale of 21,828 shares valued at $190.1K.
SPRY Insider Activity Summary
Who Is Buying SPRY Stock?
No significant insider buying has been recorded for SPRY in the recent period.
Who Is Selling SPRY Stock?
No significant insider selling has been recorded for SPRY in the recent period.
Is ARS Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SPRY is bearish with an Insider Alignment Score of 40/100 and a net flow of -$25.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SPRY Frequently Asked Questions
Understanding SPRY Insider Activity
Insider trading at ARS Pharmaceuticals, Inc. (SPRY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading SPRY stock, having executed 224 transactions in the past 90 days. The most active insider is Capital Management, L.p. Ra (Executive), who has made 4 transactions totaling $36.5M.
Related Tools
Track ARS Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SPRY file new Form 4 transactions